Surgical Treatment for Hypertrophic Cardiomyopathy: a Historical Perspective

Overview

Journal Ann Cardiothorac Surg

Publisher AME Publishing Company

Date 2017 Sep 26

PMID 28944172

Citations 12

Authors

Dustin Hang

Anita Nguyen

Hartzell V Schaff

Affiliations

Soon will be listed here.

Abstract

Our understanding of hypertrophic cardiomyopathy (HCM) as a disease entity has increased dramatically over the last half century. There has been a concerted effort by several surgical groups to develop operative techniques to relieve left ventricular outflow tract (LVOT) obstruction and alleviate symptoms. This paper traces the development of transaortic septal myectomy, the current gold standard therapy for relief of LVOT obstruction, in symptomatic patients refractory to medical treatment. In addition, we introduce newer methods for myectomy that have expanded the role of surgery in patients with various forms of HCM.

Citing Articles

The efficacy and safety of alcohol septal ablation stratified by alcohol dosage for patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis.

Elshahat A, Ellabban M, Amin A, Diaa A, Bakr A, Rzk F BMC Cardiovasc Disord. 2024; 24(1):624.

PMID: 39511466 PMC: 11542375. DOI: 10.1186/s12872-024-04194-2.

Comparing long-term outcomes of septal myectomy and mitral valve replacement in hypertrophic cardiomyopathy patients: A retrospective cohort study in Iran.

Ayati A, Khoshfetrat M, Davoodi S, Ahmadi Tafti S, Arefizadeh R Health Sci Rep. 2024; 7(4):e2045.

PMID: 38629112 PMC: 11019255. DOI: 10.1002/hsr2.2045.

Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction.

Greenbaum A, Ueyama H, Gleason P, Khan J, Bruce C, Halaby R J Am Coll Cardiol. 2024; 83(14):1257-1272.

PMID: 38471643 PMC: 10990778. DOI: 10.1016/j.jacc.2024.02.007.

PlasmaBlade-assisted surgical septal myectomy: technique and our experience.

Garg P, Lykins A, Alomari M, Reynolds J, Johnson E, Sareyyupoglu B Front Cardiovasc Med. 2024; 11:1345540.

PMID: 38357514 PMC: 10864591. DOI: 10.3389/fcvm.2024.1345540.

Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy.

Paar V, Haslinger M, Krombholz-Reindl P, Pittner S, Neuner M, Jirak P Front Pharmacol. 2023; 14:1264216.

PMID: 38074139 PMC: 10703305. DOI: 10.3389/fphar.2023.1264216.

References

Sorajja P, Valeti U, Nishimura R, Ommen S, Rihal C, Gersh B . Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008; 118(2):131-9. DOI: 10.1161/CIRCULATIONAHA.107.738740. View

TEARE D . Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958; 20(1):1-8. PMC: 492780. DOI: 10.1136/hrt.20.1.1. View

Tengiz I, Ercan E, Alioglu E, Turk U . Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report. BMC Cardiovasc Disord. 2006; 6:15. PMC: 1459201. DOI: 10.1186/1471-2261-6-15. View

KIRKLIN J, ELLIS Jr F . Surgical relief of diffuse subvalvular aortic stenosis. Circulation. 1961; 24:739-42. DOI: 10.1161/01.cir.24.4.739. View

Seggewiss H, Faber L . Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2002; 1(4):277-80. DOI: 10.1053/euje.2000.0032. View

Sorajja P, Ommen S, Holmes Jr D, Dearani J, Rihal C, Gersh B . Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012; 126(20):2374-80. DOI: 10.1161/CIRCULATIONAHA.111.076257. View

Desai M, Smedira N, Bhonsale A, Thamilarasan M, Lytle B, Lever H . Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: Relationship to outcomes. J Thorac Cardiovasc Surg. 2015; 150(4):928-35.e1. DOI: 10.1016/j.jtcvs.2015.07.063. View

Vaglio Jr J, Ommen S, Nishimura R, Tajik A, Gersh B . Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction. Am Heart J. 2008; 156(2):342-7. DOI: 10.1016/j.ahj.2008.04.002. View

Mazine A, Ghoneim A, Bouhout I, Fortin W, Berania I, LAllier P . A Novel Minimally Invasive Approach for Surgical Septal Myectomy. Can J Cardiol. 2016; 32(11):1340-1347. DOI: 10.1016/j.cjca.2016.01.034. View

10.

Sigwart U . Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995; 346(8969):211-4. DOI: 10.1016/s0140-6736(95)91267-3. View

11.

Kuc M, Kolsut P, Rozanski J, Dabrowski M, Klopotowski M, Kumor M . Extended myectomy in the treatment of patients with hypertrophic obstructive cardiomyopathy. Kardiochir Torakochirurgia Pol. 2017; 13(4):300-304. PMC: 5233757. DOI: 10.5114/kitp.2016.64868. View

12.

Morrow A, Brockenbrough E . Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg. 1961; 154:181-9. PMC: 1465878. DOI: 10.1097/00000658-196108000-00003. View

13.

Maron B, Epstein S . Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979; 43(6):1242-4. DOI: 10.1016/0002-9149(79)90160-7. View

14.

Krajcer Z, Leachman R, Cooley D, Coronado R . Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. Circulation. 1989; 80(3 Pt 1):I57-64. View

15.

Wigle E, CHRYSOHOU A, Bigelow W . Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol. 1963; 11:572-86. DOI: 10.1016/0002-9149(63)90076-6. View

16.

Angelini P, Uribe C, Monge J, Escobar J, Hernandez-Vila E . Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation. Tex Heart Inst J. 2012; 39(5):750-5. PMC: 3461680. View

17.

Wigle E, Trimble A, Adelman A, Bigelow W . Surgery in muscular subaortic stenosis. Prog Cardiovasc Dis. 1968; 11(2):83-112. DOI: 10.1016/0033-0620(68)90021-2. View

18.

Cho Y, Quintana E, Schaff H, Nishimura R, Dearani J, Abel M . Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. J Thorac Cardiovasc Surg. 2014; 148(3):909-15. DOI: 10.1016/j.jtcvs.2014.05.028. View

19.

Morrow A . Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg. 1978; 76(4):423-30. View

20.

Morrow A, Fogarty T, Hannah 3rd H, Braunwald E . Operative treatment in idiopathic hypertrophic subaortic stenosis. Techniques, and the results of preoperative and postoperative clinical and hemodynamic assessments. Circulation. 1968; 37(4):589-96. DOI: 10.1161/01.cir.37.4.589. View